FINGOLIMOD HCL

FINGOLIMOD HCL was reported 86195 times

FINGOLIMOD HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXPANDED DISABILITY STATUS SCALE 45 0.6000
1 TUMEFACTIVE MULTIPLE SCLEROSIS 99 0.5824
2 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 676 0.5417
3 JC VIRUS TEST POSITIVE 238 0.2827
4 JC POLYOMAVIRUS TEST POSITIVE 277 0.2365
5 CENTRAL NERVOUS SYSTEM LESION 2905 0.2112
6 LYMPHOCYTE COUNT DECREASED 3556 0.2010
7 GAIT SPASTIC 67 0.1953
8 CRYPTOCOCCAL CUTANEOUS INFECTION 33 0.1813
9 CD8 LYMPHOCYTES DECREASED 34 0.1692
10 DECREASED VIBRATORY SENSE 57 0.1676
11 RELAPSING-REMITTING MULTIPLE SCLEROSIS 141 0.1632
12 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 292 0.1552
13 MACULAR OEDEMA 866 0.1544
14 FIBROUS HISTIOCYTOMA 54 0.1538
15 HAEMANGIOMA OF SKIN 64 0.1468
16 LENTIGO 71 0.1431
17 DRUG MONITORING PROCEDURE NOT PERFORMED 238 0.1324
18 LYMPHOPENIA 1671 0.1180
19 MULTIPLE SCLEROSIS RELAPSE 7765 0.1132
20 RELAPSING MULTIPLE SCLEROSIS 34 0.1126
21 BASOPHIL COUNT DECREASED 29 0.1098
22 LYMPHOMATOID PAPULOSIS 31 0.1058
23 LYMPHOCYTE COUNT ABNORMAL 115 0.1021
24 DYSPLASTIC NAEVUS 36 0.0997
25 MOLLUSCUM CONTAGIOSUM 53 0.0981
26 SEBORRHOEIC KERATOSIS 141 0.0970
27 DELIVERY 60 0.0910
28 LYMPHOCYTE PERCENTAGE DECREASED 116 0.0863
29 ATRIOVENTRICULAR BLOCK FIRST DEGREE 364 0.0839
30 PARAPARESIS 148 0.0830
31 OPTIC NEURITIS 748 0.0822
32 MELANOCYTIC NAEVUS 352 0.0802
33 BAND SENSATION 101 0.0796
34 T-LYMPHOCYTE COUNT DECREASED 54 0.0792
35 ATRIOVENTRICULAR BLOCK SECOND DEGREE 240 0.0790
36 PROGRESSIVE MULTIPLE SCLEROSIS 90 0.0779
37 CD4 LYMPHOCYTES DECREASED 163 0.0761
38 BLOOD BILIRUBIN DECREASED 47 0.0761
39 MENINGITIS CRYPTOCOCCAL 133 0.0760
40 HEART RATE DECREASED 2638 0.0750
41 CONCOMITANT DISEASE AGGRAVATED 463 0.0749
42 SOLAR LENTIGO 69 0.0727
43 MONOCYTE PERCENTAGE INCREASED 51 0.0719
44 BLADDER DYSFUNCTION 74 0.0719
45 HUMAN PAPILLOMA VIRUS TEST POSITIVE 29 0.0713
46 HIGH DENSITY LIPOPROTEIN INCREASED 70 0.0704
47 ELECTROCARDIOGRAM PR PROLONGATION 53 0.0693
48 BLOOD ALKALINE PHOSPHATASE DECREASED 65 0.0685
49 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS 33 0.0682
50 JC VIRUS INFECTION 107 0.0669
51 EXTENSOR PLANTAR RESPONSE 61 0.0662
52 NORMAL NEWBORN 349 0.0641
53 ANOGENITAL WARTS 55 0.0617
54 DECREASED INTEREST 361 0.0612
55 OPHTHALMOPLEGIA 96 0.0608
56 ASPARTATE AMINOTRANSFERASE DECREASED 32 0.0604
57 PLEOCYTOSIS 35 0.0601
58 DYSMETRIA 36 0.0596
59 PARESIS 128 0.0574
60 PRESCRIBED UNDERDOSE 1141 0.0571
61 VISCERAL LEISHMANIASIS 41 0.0568
62 NEUTROPHIL PERCENTAGE INCREASED 71 0.0563
63 WHITE MATTER LESION 70 0.0554
64 OPTIC ATROPHY 88 0.0540
65 BRAIN STEM SYNDROME 40 0.0533
66 PAPILLOMA VIRAL INFECTION 88 0.0533
67 HEMIANAESTHESIA 42 0.0526
68 MUSCLE SPASTICITY 632 0.0514
69 MULTIPLE SCLEROSIS 2433 0.0508
70 NEUROGENIC BLADDER 106 0.0502
71 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 33 0.0498
72 TRIGEMINAL NEURALGIA 198 0.0492
73 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 398 0.0482
74 CERVICAL DYSPLASIA 105 0.0481
75 LYMPHOCYTE COUNT INCREASED 148 0.0453
76 CSF PROTEIN INCREASED 36 0.0434
77 MATERNAL EXPOSURE TIMING UNSPECIFIED 163 0.0434
78 CYSTOID MACULAR OEDEMA 81 0.0429
79 CRYPTOCOCCOSIS 70 0.0429
80 ALANINE AMINOTRANSFERASE DECREASED 31 0.0428
81 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 212 0.0425
82 OPTIC NERVE DISORDER 67 0.0418
83 SENSORY LOSS 327 0.0406
84 MONOCYTE COUNT INCREASED 147 0.0404
85 MONOPARESIS 72 0.0398
86 PERONEAL NERVE PALSY 222 0.0390
87 CLUMSINESS 106 0.0388
88 TEMPERATURE INTOLERANCE 398 0.0385
89 SINUS ARRHYTHMIA 50 0.0383
90 HEMIPARESIS 646 0.0381
91 ATAXIA 452 0.0380
92 DYSGRAPHIA 250 0.0379
93 POST HERPETIC NEURALGIA 54 0.0376
94 DYSCHROMATOPSIA 31 0.0374
95 COLOUR BLINDNESS 34 0.0370
96 WHITE BLOOD CELL COUNT DECREASED 3989 0.0368
97 DEMYELINATION 148 0.0361
98 EXPOSURE VIA FATHER 47 0.0360
99 INTRADUCTAL PROLIFERATIVE BREAST LESION 45 0.0359
100 RETINAL OEDEMA 68 0.0355
101 DECREASED IMMUNE RESPONSIVENESS 346 0.0352
102 ELECTROCARDIOGRAM T WAVE ABNORMAL 55 0.0352
103 REBOUND EFFECT 398 0.0352
104 SINUS BRADYCARDIA 337 0.0348
105 VACCINATION FAILURE 56 0.0337
106 OPTIC NERVE INJURY 39 0.0336
107 LIMB DISCOMFORT 1030 0.0333
108 HEMIANOPIA 32 0.0323
109 GAMMA-GLUTAMYLTRANSFERASE INCREASED 701 0.0316
110 ACROCHORDON 41 0.0309
111 INVASIVE DUCTAL BREAST CARCINOMA 84 0.0309
112 QUADRIPARESIS 51 0.0307
113 MICTURITION URGENCY 347 0.0303
114 CEREBELLAR SYNDROME 66 0.0301
115 ELECTROCARDIOGRAM ABNORMAL 233 0.0297
116 DYSAESTHESIA 91 0.0297
117 MONOCYTE COUNT DECREASED 36 0.0295
118 MAGNETIC RESONANCE IMAGING ABNORMAL 35 0.0293
119 TINEA INFECTION 32 0.0290
120 MYELITIS 43 0.0277
121 MYELITIS TRANSVERSE 39 0.0277
122 BASAL CELL CARCINOMA 428 0.0274
123 MATERNAL EXPOSURE BEFORE PREGNANCY 187 0.0273
124 ELECTROCARDIOGRAM T WAVE INVERSION 60 0.0271
125 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 90 0.0271
126 BALANCE DISORDER 2322 0.0268
127 GENITAL HERPES 41 0.0268
128 MALIGNANT MELANOMA IN SITU 33 0.0266
129 SKIN PAPILLOMA 106 0.0264
130 SPINAL CORD DISORDER 43 0.0261
131 OPHTHALMIC HERPES ZOSTER 47 0.0260
132 NEUROMYELITIS OPTICA SPECTRUM DISORDER 35 0.0259
133 NYSTAGMUS 136 0.0256
134 CERVIX CARCINOMA 100 0.0256
135 SMEAR CERVIX ABNORMAL 36 0.0253
136 VITAMIN D DEFICIENCY 247 0.0253
137 HYPOAESTHESIA 3770 0.0252
138 HAEMANGIOMA 58 0.0251
139 BLADDER DISORDER 249 0.0251
140 VARICELLA ZOSTER VIRUS INFECTION 50 0.0241
141 DIPLOPIA 618 0.0238
142 COGNITIVE DISORDER 1109 0.0237
143 VISUAL FIELD DEFECT 171 0.0236
144 SPINAL CORD INJURY 41 0.0235
145 QUADRIPLEGIA 48 0.0233
146 SENSORY DISTURBANCE 374 0.0233
147 CEREBRAL ATROPHY 91 0.0228
148 FINE MOTOR SKILL DYSFUNCTION 66 0.0228
149 ACTINIC KERATOSIS 59 0.0227
150 WHITE BLOOD CELL DISORDER 60 0.0224
151 MOVEMENT DISORDER 717 0.0223
152 MIGRAINE WITH AURA 60 0.0221
153 HEPATIC ENZYME ABNORMAL 110 0.0220
154 TINEA PEDIS 35 0.0219
155 HEPATIC ENZYME INCREASED 1477 0.0216
156 MEMORY IMPAIRMENT 2969 0.0216
157 HYPERREFLEXIA 75 0.0215
158 BODY MASS INDEX INCREASED 29 0.0215
159 MEAN CELL HAEMOGLOBIN INCREASED 35 0.0211
160 MALIGNANT MELANOMA 282 0.0210
161 VISUAL IMPAIRMENT 2606 0.0210
162 LIVER FUNCTION TEST INCREASED 451 0.0210
163 COORDINATION ABNORMAL 293 0.0210
164 EOSINOPHIL COUNT DECREASED 50 0.0210
165 BRADYCARDIA 1072 0.0202
166 ASTHENOPIA 111 0.0202
167 METAMORPHOPSIA 37 0.0201
168 GAIT DISTURBANCE 3837 0.0200
169 RETINAL DISORDER 52 0.0200
170 IMMUNE THROMBOCYTOPENIC PURPURA 56 0.0198
171 HYPERTONIC BLADDER 57 0.0197
172 MONOPLEGIA 85 0.0195
173 MOTOR DYSFUNCTION 199 0.0195
174 ALANINE AMINOTRANSFERASE INCREASED 1197 0.0195
175 HERPES ZOSTER 1120 0.0195
176 NEUTROPHIL COUNT INCREASED 199 0.0194
177 VERTIGO POSITIONAL 34 0.0194
178 MUSCULAR WEAKNESS 2205 0.0194
179 MENTAL FATIGUE 29 0.0193
180 ASTIGMATISM 29 0.0191
181 MYOPIA 45 0.0189
182 URINARY HESITATION 45 0.0188
183 IMMUNODEFICIENCY 281 0.0188
184 VISION BLURRED 2577 0.0187
185 INFECTION SUSCEPTIBILITY INCREASED 41 0.0187
186 MOTION SICKNESS 36 0.0187
187 VITAMIN D DECREASED 159 0.0186
188 CERVICAL SPINAL STENOSIS 32 0.0186
189 MEAN CELL HAEMOGLOBIN DECREASED 34 0.0186
190 READING DISORDER 42 0.0184
191 PARAPLEGIA 53 0.0183
192 URINARY INCONTINENCE 542 0.0183
193 LOW DENSITY LIPOPROTEIN INCREASED 141 0.0182
194 WHITE BLOOD CELLS URINE POSITIVE 34 0.0181
195 SUPRAVENTRICULAR EXTRASYSTOLES 61 0.0180
196 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 30 0.0180
197 HYPOKINESIA 259 0.0178
198 BLEPHAROSPASM 111 0.0176
199 HEMIPLEGIA 145 0.0174
200 VITREOUS FLOATERS 171 0.0174
201 FRUSTRATION TOLERANCE DECREASED 140 0.0173
202 DIZZINESS POSTURAL 168 0.0173
203 INCONTINENCE 182 0.0172
204 RED CELL DISTRIBUTION WIDTH INCREASED 71 0.0171
205 HAEMATOCRIT INCREASED 38 0.0167
206 HEART RATE ABNORMAL 92 0.0165
207 CEREBRAL DISORDER 122 0.0165
208 FACIAL PAIN 147 0.0165
209 NON-CARDIAC CHEST PAIN 52 0.0164
210 DYSPHEMIA 72 0.0164
211 MACULOPATHY 57 0.0161
212 TONGUE BITING 33 0.0160
213 EYE MOVEMENT DISORDER 109 0.0159
214 VISUAL ACUITY REDUCED 528 0.0159
215 EXTRASYSTOLES 110 0.0157
216 DEPRESSED MOOD 828 0.0156
217 ATROPHY 30 0.0154
218 BLOOD ALKALINE PHOSPHATASE INCREASED 383 0.0154
219 DYSARTHRIA 576 0.0153
220 PROTEIN TOTAL DECREASED 57 0.0151
221 EYE PAIN 854 0.0151
222 PARAESTHESIA 2380 0.0151
223 BLINDNESS TRANSIENT 111 0.0150
224 PHOTOPSIA 95 0.0150
225 STRABISMUS 44 0.0150
226 SQUAMOUS CELL CARCINOMA 140 0.0149
227 PHOTOPHOBIA 279 0.0148
228 NEURALGIA 358 0.0147
229 DIPLEGIA 29 0.0146
230 OCULAR DISCOMFORT 164 0.0146
231 BLOOD IMMUNOGLOBULIN G DECREASED 36 0.0145
232 ANAL INCONTINENCE 129 0.0143
233 IMMUNOSUPPRESSION 126 0.0143
234 LIGAMENT SPRAIN 141 0.0142
235 FACIAL PARALYSIS 121 0.0142
236 FACIAL PARESIS 50 0.0141
237 BREAST MASS 94 0.0140
238 WHITE BLOOD CELL COUNT ABNORMAL 89 0.0139
239 BUNDLE BRANCH BLOCK RIGHT 64 0.0139
240 SQUAMOUS CELL CARCINOMA OF SKIN 84 0.0139
241 FATIGUE 10807 0.0139
242 APHASIA 418 0.0138
243 SPEECH DISORDER 722 0.0138
244 BLOOD CREATININE DECREASED 43 0.0137
245 EYE DISORDER 451 0.0137
246 ASPARTATE AMINOTRANSFERASE INCREASED 724 0.0136
247 ELECTROENCEPHALOGRAM ABNORMAL 43 0.0136
248 VITAMIN B12 DEFICIENCY 55 0.0136
249 VERTIGO 821 0.0135
250 BLOOD PRESSURE DECREASED 890 0.0134
251 MUSCLE TIGHTNESS 216 0.0133
252 LEUKOPENIA 664 0.0133
253 VIRAL UPPER RESPIRATORY TRACT INFECTION 63 0.0132
254 TENSION HEADACHE 56 0.0130
255 RETINAL VEIN OCCLUSION 37 0.0129
256 AMNESIA 836 0.0128
257 HERPES VIRUS INFECTION 74 0.0128
258 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 92 0.0128
259 MATERNAL EXPOSURE DURING PREGNANCY 1140 0.0128
260 SLOW SPEECH 31 0.0128
261 IMMUNE SYSTEM DISORDER 168 0.0127
262 HEAD DISCOMFORT 225 0.0127
263 B-CELL LYMPHOMA 43 0.0126
264 VENTRICULAR EXTRASYSTOLES 131 0.0126
265 PARTIAL SEIZURES 66 0.0126
266 RETINAL TEAR 31 0.0126
267 ABNORMAL SENSATION IN EYE 54 0.0125
268 PARALYSIS 179 0.0125
269 MIGRAINE 1191 0.0125
270 URINE ODOUR ABNORMAL 73 0.0124
271 SENSATION OF HEAVINESS 48 0.0124
272 MOBILITY DECREASED 883 0.0123
273 SKIN LESION 337 0.0123
274 CARDIAC FLUTTER 79 0.0122
275 MUSCLE FATIGUE 51 0.0120
276 SKIN CANCER 259 0.0120
277 ABORTION 35 0.0120
278 ESCHERICHIA URINARY TRACT INFECTION 51 0.0120
279 DYSSTASIA 350 0.0120
280 SPINAL PAIN 139 0.0119
281 FUNCTIONAL GASTROINTESTINAL DISORDER 41 0.0118
282 VITAMIN B12 DECREASED 34 0.0118
283 HYPERTONIA 67 0.0117
284 AUTOIMMUNE HAEMOLYTIC ANAEMIA 40 0.0117
285 RED BLOOD CELL COUNT INCREASED 32 0.0116
286 HEADACHE 7272 0.0116
287 SLUGGISHNESS 117 0.0115
288 DEPRESSION 2580 0.0113
289 MEAN CELL VOLUME INCREASED 29 0.0113
290 THYROID MASS 43 0.0112
291 NASOPHARYNGITIS 2041 0.0111
292 BLINDNESS UNILATERAL 156 0.0110
293 BLINDNESS 450 0.0110
294 LIVER FUNCTION TEST ABNORMAL 319 0.0110
295 INTENTIONAL UNDERDOSE 79 0.0108
296 FACE INJURY 41 0.0108
297 DIZZINESS 5373 0.0108
298 BACK PAIN 2499 0.0107
299 VIITH NERVE PARALYSIS 37 0.0107
300 CHEST DISCOMFORT 1094 0.0107
301 LUNG ADENOCARCINOMA 32 0.0106
302 ATRIOVENTRICULAR BLOCK 82 0.0106
303 OROPHARYNGEAL PAIN 979 0.0106
304 PRODUCT DOSE OMISSION 689 0.0105
305 FALL 3493 0.0105
306 IMMUNE THROMBOCYTOPENIA 48 0.0105
307 VULVOVAGINAL MYCOTIC INFECTION 41 0.0104
308 FUNGAL SKIN INFECTION 42 0.0104
309 NECK PAIN 581 0.0104
310 GRIP STRENGTH DECREASED 90 0.0102
311 PERIPHERAL COLDNESS 138 0.0100
312 HEART RATE IRREGULAR 227 0.0100
313 URINE ANALYSIS ABNORMAL 30 0.0100
314 GAIT INABILITY 335 0.0100
315 CONCUSSION 77 0.0099
316 PAPULE 70 0.0099
317 DEPRESSIVE SYMPTOM 35 0.0099
318 CYSTITIS 316 0.0099
319 PARANASAL SINUS DISCOMFORT 37 0.0098
320 SOMNOLENCE 1959 0.0097
321 FEELING ABNORMAL 2328 0.0097
322 UTERINE LEIOMYOMA 71 0.0097
323 ELECTROCARDIOGRAM QT PROLONGED 347 0.0096
324 ORAL HERPES 188 0.0096
325 MUSCLE RIGIDITY 115 0.0096
326 VAGINAL INFECTION 45 0.0096
327 HYPOAESTHESIA ORAL 144 0.0095
328 URINARY TRACT INFECTION 1628 0.0095
329 MUSCULOSKELETAL STIFFNESS 834 0.0095
330 BLADDER PAIN 30 0.0094
331 HERPES SIMPLEX 61 0.0094
332 PALPITATIONS 1099 0.0094
333 UPPER RESPIRATORY TRACT INFECTION 432 0.0093
334 ABASIA 231 0.0093
335 ABORTION SPONTANEOUS 373 0.0093
336 THERMAL BURN 66 0.0093
337 FRUSTRATION 33 0.0092
338 DECUBITUS ULCER 75 0.0092
339 ANKLE FRACTURE 142 0.0092
340 CORONAVIRUS INFECTION 60 0.0091
341 RESTLESS LEGS SYNDROME 165 0.0091
342 PANIC DISORDER 35 0.0090
343 GLAUCOMA 174 0.0090
344 EPILEPSY 275 0.0090
345 SPINAL OSTEOARTHRITIS 79 0.0090
346 ANXIETY DISORDER 30 0.0090
347 LOSS OF CONTROL OF LEGS 34 0.0090
348 INFLUENZA 997 0.0089
349 NERVOUSNESS 467 0.0089
350 INTERVERTEBRAL DISC DISORDER 38 0.0089
351 PAIN IN EXTREMITY 2620 0.0089
352 DIABETIC RETINOPATHY 30 0.0088
353 INTERVERTEBRAL DISC PROTRUSION 193 0.0088
354 LIGAMENT RUPTURE 39 0.0088
355 HIGH DENSITY LIPOPROTEIN DECREASED 29 0.0087
356 BLOOD PRESSURE DIASTOLIC INCREASED 40 0.0087
357 MICTURITION DISORDER 30 0.0086
358 PIGMENTATION DISORDER 53 0.0086
359 HAEMATOCRIT DECREASED 170 0.0086
360 MUSCULOSKELETAL DISCOMFORT 146 0.0085
361 FEELING COLD 235 0.0084
362 BLOOD CHOLESTEROL INCREASED 393 0.0084
363 RETINAL HAEMORRHAGE 60 0.0084
364 PRODUCT DISPENSING ISSUE 36 0.0084
365 EAR PAIN 163 0.0084
366 MUSCLE SPASMS 1531 0.0083
367 MUSCLE STRAIN 72 0.0083
368 MOOD ALTERED 226 0.0083
369 SINUS HEADACHE 49 0.0082
370 BLOOD ALBUMIN DECREASED 65 0.0082
371 FEELING OF BODY TEMPERATURE CHANGE 48 0.0082
372 BURNING SENSATION 570 0.0081
373 INFLUENZA LIKE ILLNESS 669 0.0081
374 PRODUCT SUPPLY ISSUE 58 0.0081
375 DISTURBANCE IN ATTENTION 437 0.0081
376 BLOOD PRESSURE INCREASED 1233 0.0081
377 BLOOD PRESSURE FLUCTUATION 193 0.0080
378 POLLAKIURIA 334 0.0080
379 TREMOR 1324 0.0080
380 MACULAR DEGENERATION 95 0.0079
381 URINARY RETENTION 265 0.0079
382 HYPERVENTILATION 46 0.0079
383 SINUSITIS 811 0.0079
384 FAECAL INCONTINENCE 38 0.0079
385 ENERGY INCREASED 46 0.0078
386 SEASONAL ALLERGY 110 0.0078
387 FOOT FRACTURE 147 0.0077
388 ONYCHOMYCOSIS 34 0.0077
389 WHITE BLOOD CELL COUNT INCREASED 297 0.0077
390 ROSACEA 36 0.0077
391 URINE ABNORMALITY 35 0.0077
392 NEUROLOGICAL SYMPTOM 44 0.0077
393 INTERVERTEBRAL DISC DEGENERATION 71 0.0077
394 ASTHENIA 2873 0.0076
395 CHEST PAIN 1407 0.0076
396 CHROMATURIA 171 0.0076
397 STATUS EPILEPTICUS 85 0.0075
398 ENCEPHALITIS 52 0.0075
399 MUSCLE TWITCHING 173 0.0075
400 HEPATIC PAIN 32 0.0075
401 HAND FRACTURE 53 0.0075
402 BLOOD BILIRUBIN INCREASED 202 0.0075
403 GASTROENTERITIS VIRAL 135 0.0075
404 FEAR 201 0.0075
405 INTRACRANIAL ANEURYSM 30 0.0075
406 OVERWEIGHT 40 0.0074
407 DEAFNESS UNILATERAL 41 0.0074
408 PERSONALITY CHANGE 69 0.0074
409 DIFFUSE LARGE B-CELL LYMPHOMA 57 0.0074
410 MENSTRUAL DISORDER 61 0.0074
411 FEELING OF DESPAIR 34 0.0073
412 FOOD POISONING 39 0.0073
413 TONSILLITIS 38 0.0073
414 AFFECT LABILITY 70 0.0073
415 SINUS DISORDER 144 0.0073
416 SEIZURE 838 0.0072
417 HAEMOGLOBIN INCREASED 33 0.0072
418 ANGINA PECTORIS 207 0.0072
419 MALAISE 3132 0.0071
420 URINARY TRACT DISORDER 32 0.0071
421 BUNDLE BRANCH BLOCK LEFT 30 0.0071
422 DYSURIA 260 0.0071
423 EYE HAEMORRHAGE 94 0.0070
424 FEELING JITTERY 134 0.0070
425 VIRAL INFECTION 233 0.0070
426 AFFECTIVE DISORDER 55 0.0070
427 BRAIN INJURY 70 0.0070
428 PANIC ATTACK 254 0.0070
429 APHTHOUS ULCER 54 0.0070
430 LOWER LIMB FRACTURE 133 0.0069
431 MUSCULOSKELETAL CHEST PAIN 107 0.0069
432 LIVER DISORDER 304 0.0068
433 BRONCHITIS 503 0.0068
434 PHARYNGITIS 84 0.0068
435 FEELING HOT 415 0.0068
436 PHARYNGITIS STREPTOCOCCAL 73 0.0067
437 JOINT INJURY 144 0.0067
438 CONFUSIONAL STATE 1089 0.0067
439 APHONIA 94 0.0067
440 EYE INFECTION 76 0.0067
441 OVARIAN CYST 67 0.0067
442 HORDEOLUM 29 0.0067
443 GASTROINTESTINAL INFECTION 60 0.0067
444 RED BLOOD CELL COUNT DECREASED 191 0.0067
445 INTRAOCULAR PRESSURE INCREASED 85 0.0066
446 PAPILLOEDEMA 30 0.0066
447 HUMERUS FRACTURE 32 0.0066
448 CRYING 241 0.0066
449 ALOPECIA 1297 0.0066
450 RHINITIS 53 0.0066
451 HYPERTENSION 1389 0.0066
452 EAR DISORDER 30 0.0065
453 BLOOD TEST ABNORMAL 92 0.0065
454 COUGH 1835 0.0065
455 FLANK PAIN 61 0.0065
456 MUSCULOSKELETAL PAIN 340 0.0065
457 TRANSAMINASES INCREASED 144 0.0065
458 HUNGER 90 0.0065
459 HYPERAESTHESIA 53 0.0064
460 DISEASE RECURRENCE 306 0.0064
461 BRADYPHRENIA 42 0.0064
462 BODY TEMPERATURE INCREASED 131 0.0064
463 HEAD INJURY 203 0.0064
464 BRAIN OEDEMA 81 0.0064
465 PREMATURE DELIVERY 102 0.0064
466 CONTUSION 614 0.0064
467 ROAD TRAFFIC ACCIDENT 265 0.0063
468 ACCIDENT 75 0.0063
469 UVEITIS 85 0.0063
470 PYELONEPHRITIS 54 0.0062
471 HEPATIC STEATOSIS 116 0.0062
472 EAR DISCOMFORT 63 0.0061
473 HEPATOCELLULAR INJURY 87 0.0061
474 SPINAL DISORDER 58 0.0061
475 PSYCHIATRIC SYMPTOM 45 0.0061
476 WALKING AID USER 40 0.0061
477 SUNBURN 45 0.0060
478 WRIST FRACTURE 72 0.0060
479 GENERALISED TONIC-CLONIC SEIZURE 99 0.0060
480 BLOOD CALCIUM DECREASED 67 0.0060
481 POOR QUALITY SLEEP 128 0.0059
482 BLOOD TRIGLYCERIDES INCREASED 105 0.0059
483 BLOOD PRESSURE ABNORMAL 118 0.0059
484 ANXIETY 1689 0.0059
485 LYMPHOEDEMA 41 0.0059
486 COVID-19 PNEUMONIA 70 0.0059
487 FEELING DRUNK 44 0.0059
488 SLEEP DISORDER 416 0.0059
489 HYPERSOMNIA 168 0.0059
490 DYSKINESIA 237 0.0058
491 GASTROENTERITIS 85 0.0058
492 DYSPHAGIA 552 0.0058
493 VARICOSE VEIN 30 0.0058
494 BREAST CANCER 541 0.0058
495 CYST 72 0.0058
496 EYE DISCHARGE 60 0.0058
497 VENTRICULAR SEPTAL DEFECT 33 0.0058
498 EOSINOPHIL COUNT INCREASED 48 0.0058
499 HEART RATE INCREASED 567 0.0057
500 TOOTH ABSCESS 58 0.0057
501 RESPIRATORY TRACT INFECTION 148 0.0057
502 TENDERNESS 59 0.0057
503 KIDNEY INFECTION 111 0.0057
504 NASAL CONGESTION 330 0.0056
505 MENTAL IMPAIRMENT 136 0.0056
506 FULL BLOOD COUNT DECREASED 113 0.0056
507 FUNGAL INFECTION 186 0.0056
508 GRAND MAL CONVULSION 51 0.0055
509 ABDOMINAL DISCOMFORT 916 0.0055
510 APPENDICITIS 51 0.0055
511 LYMPHADENOPATHY 193 0.0054
512 EYE SWELLING 202 0.0054
513 BIPOLAR DISORDER 59 0.0054
514 NERVE COMPRESSION 50 0.0054
515 BLOOD COUNT ABNORMAL 82 0.0054
516 RHINORRHOEA 349 0.0054
517 THERAPY CESSATION 277 0.0054
518 CONVULSION 307 0.0054
519 MENISCUS INJURY 33 0.0054
520 CARPAL TUNNEL SYNDROME 75 0.0053
521 EATING DISORDER 114 0.0053
522 EAR INFECTION 142 0.0053
523 SCIATICA 85 0.0053
524 SCOLIOSIS 33 0.0053
525 UPPER LIMB FRACTURE 106 0.0053
526 EXTRA DOSE ADMINISTERED 215 0.0053
527 ARRHYTHMIA 251 0.0053
528 INSOMNIA 1403 0.0053
529 EMOTIONAL DISORDER 162 0.0052
530 BREAST PAIN 56 0.0052
531 TOOTHACHE 95 0.0052
532 DISORIENTATION 207 0.0052
533 LOSS OF CONSCIOUSNESS 666 0.0052
534 NEPHROLITHIASIS 238 0.0052
535 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 369 0.0052
536 HYPERCHOLESTEROLAEMIA 50 0.0052
537 PRODUCT AVAILABILITY ISSUE 117 0.0051
538 EYE INFLAMMATION 49 0.0051
539 BRAIN NEOPLASM 47 0.0051
540 RETINAL DETACHMENT 47 0.0051
541 FULL BLOOD COUNT ABNORMAL 54 0.0051
542 BOWEL MOVEMENT IRREGULARITY 39 0.0051
543 SNEEZING 113 0.0050
544 NEUTROPHIL COUNT DECREASED 205 0.0050
545 LIMB INJURY 136 0.0050
546 APATHY 73 0.0050
547 SARS-COV-2 TEST POSITIVE 66 0.0050
548 COVID-19 873 0.0050
549 DENTAL CARIES 55 0.0050
550 BACK INJURY 54 0.0050
551 INCOHERENT 32 0.0049
552 HYPERTENSIVE CRISIS 55 0.0049
553 TINNITUS 227 0.0049
554 PYREXIA 1709 0.0049
555 LOW BIRTH WEIGHT BABY 39 0.0049
556 SYNCOPE 489 0.0049
557 MUSCULOSKELETAL DISORDER 93 0.0049
558 FORMICATION 34 0.0049
559 SINUS CONGESTION 66 0.0049
560 NERVOUS SYSTEM DISORDER 152 0.0049
561 ARTHROPOD BITE 36 0.0049
562 PHOTOSENSITIVITY REACTION 80 0.0048
563 THINKING ABNORMAL 90 0.0048
564 MUSCLE DISORDER 39 0.0048
565 WEIGHT INCREASED 1078 0.0048
566 RIB FRACTURE 99 0.0048
567 MENORRHAGIA 94 0.0048
568 UROSEPSIS 44 0.0048
569 CHOKING 93 0.0048
570 POLYURIA 39 0.0048
571 PLATELET COUNT INCREASED 62 0.0048
572 GASTRITIS 125 0.0047
573 PAIN 2916 0.0047
574 UTERINE CANCER 38 0.0047
575 SKIN INFECTION 53 0.0047
576 PREMATURE BABY 142 0.0047
577 CHILLS 553 0.0047
578 MENTAL DISORDER 205 0.0047
579 TONGUE DISORDER 34 0.0047
580 LETHARGY 269 0.0047
581 BLOOD THYROID STIMULATING HORMONE INCREASED 43 0.0047
582 OVARIAN CANCER 43 0.0047
583 SLEEP APNOEA SYNDROME 89 0.0047
584 MENINGITIS 31 0.0046
585 BLOOD UREA INCREASED 77 0.0046
586 WEIGHT FLUCTUATION 48 0.0046
587 PULMONARY MASS 68 0.0046
588 GENERAL PHYSICAL HEALTH DETERIORATION 527 0.0046
589 HYPOACUSIS 196 0.0045
590 FURUNCLE 36 0.0045
591 JOINT DISLOCATION 48 0.0045
592 DISCOMFORT 276 0.0045
593 DRY EYE 225 0.0045
594 CARDIAC MURMUR 39 0.0045
595 NOCTURIA 54 0.0044
596 COLD SWEAT 78 0.0044
597 GENERAL PHYSICAL CONDITION ABNORMAL 30 0.0044
598 CHOLELITHIASIS 145 0.0044
599 FOETAL EXPOSURE DURING PREGNANCY 359 0.0044
600 RENAL CYST 35 0.0044
601 GENERAL SYMPTOM 33 0.0044
602 TENDONITIS 68 0.0044
603 INITIAL INSOMNIA 45 0.0044
604 WEIGHT DECREASED 1221 0.0044
605 LACRIMATION INCREASED 132 0.0044
606 SEXUAL DYSFUNCTION 51 0.0043
607 NAUSEA 3432 0.0043
608 SKIN DISCOLOURATION 199 0.0043
609 NIGHT SWEATS 139 0.0043
610 BLOOD IRON DECREASED 51 0.0043
611 METASTASES TO LYMPH NODES 29 0.0043
612 PRODUCTIVE COUGH 205 0.0043
613 RESPIRATORY RATE INCREASED 38 0.0043
614 SCRATCH 45 0.0043
615 ABDOMINAL PAIN UPPER 873 0.0042
616 IMPAIRED HEALING 139 0.0042
617 HYPOTONIA 42 0.0042
618 HOT FLUSH 317 0.0042
619 CONJUNCTIVITIS 78 0.0042
620 FLUSHING 427 0.0042
621 IRRITABLE BOWEL SYNDROME 90 0.0042
622 ACCIDENTAL OVERDOSE 153 0.0042
623 HEPATOMEGALY 41 0.0042
624 PARAESTHESIA ORAL 60 0.0042
625 THYROID CANCER 50 0.0042
626 HICCUPS 34 0.0041
627 BLOOD DISORDER 33 0.0041
628 PRESYNCOPE 100 0.0041
629 TOOTH INFECTION 54 0.0041
630 MASS 57 0.0041
631 DYSPEPSIA 400 0.0041
632 FOOT DEFORMITY 45 0.0041
633 RENAL PAIN 43 0.0041
634 BLOOD PRESSURE SYSTOLIC INCREASED 79 0.0040
635 NERVE INJURY 45 0.0040
636 CATARACT 241 0.0040
637 EYELID PTOSIS 41 0.0040
638 SCAR 69 0.0040
639 BODY HEIGHT DECREASED 43 0.0040
640 ORAL PAIN 90 0.0040
641 DYSPHONIA 234 0.0040
642 SUPRAVENTRICULAR TACHYCARDIA 38 0.0040
643 MOOD SWINGS 126 0.0039
644 DYSPNOEA 2237 0.0039
645 PRODUCT DOSE OMISSION ISSUE 1161 0.0039
646 LACERATION 37 0.0039
647 BLOOD POTASSIUM DECREASED 118 0.0039
648 DYSGEUSIA 290 0.0039
649 DEAFNESS 102 0.0039
650 DRY MOUTH 316 0.0039
651 LYMPHOMA 60 0.0039
652 INFLAMMATION 200 0.0039
653 OROPHARYNGEAL DISCOMFORT 35 0.0039
654 GROIN PAIN 34 0.0039
655 MUSCLE ATROPHY 49 0.0039
656 DRUG INTOLERANCE 370 0.0038
657 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 36 0.0038
658 SCAB 43 0.0038
659 BACK DISORDER 61 0.0037
660 THIRST 67 0.0037
661 PETECHIAE 39 0.0037
662 TOOTH FRACTURE 41 0.0037
663 INFECTION 538 0.0037
664 CHOLECYSTITIS 44 0.0037
665 IRRITABILITY 221 0.0037
666 ASPHYXIA 30 0.0037
667 SECRETION DISCHARGE 46 0.0037
668 ANGER 124 0.0037
669 SINUS TACHYCARDIA 52 0.0037
670 ROTATOR CUFF SYNDROME 47 0.0037
671 BODY TEMPERATURE DECREASED 36 0.0037
672 C-REACTIVE PROTEIN INCREASED 133 0.0037
673 MOUTH ULCERATION 77 0.0037
674 UPPER-AIRWAY COUGH SYNDROME 30 0.0036
675 OBESITY 58 0.0036
676 DECREASED ACTIVITY 39 0.0036
677 HYPERLIPIDAEMIA 43 0.0036
678 TACHYCARDIA 318 0.0036
679 THYROID DISORDER 55 0.0036
680 ABDOMINAL PAIN 827 0.0036
681 FIBROMYALGIA 86 0.0035
682 PNEUMONIA ASPIRATION 88 0.0035
683 INCREASED APPETITE 67 0.0035
684 EXOSTOSIS 32 0.0035
685 GLOMERULAR FILTRATION RATE DECREASED 43 0.0035
686 CONSTIPATION 763 0.0035
687 LOCAL SWELLING 61 0.0035
688 PAIN IN JAW 99 0.0035
689 ORAL CANDIDIASIS 46 0.0035
690 HYPERSENSITIVITY 648 0.0035
691 PULMONARY CONGESTION 46 0.0035
692 GASTROINTESTINAL DISORDER 312 0.0035
693 NEOPLASM MALIGNANT 232 0.0035
694 JOINT STIFFNESS 91 0.0035
695 DECREASED APPETITE 805 0.0035
696 ATRIAL SEPTAL DEFECT 29 0.0035
697 HEPATITIS 88 0.0034
698 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38 0.0034
699 ATELECTASIS 33 0.0034
700 HYPOTHYROIDISM 109 0.0034
701 BURSITIS 41 0.0034
702 CARDIAC DISORDER 316 0.0034
703 BLOOD URINE PRESENT 64 0.0034
704 AMENORRHOEA 59 0.0034
705 GASTROINTESTINAL PAIN 37 0.0034
706 MITRAL VALVE INCOMPETENCE 38 0.0034
707 OEDEMA PERIPHERAL 405 0.0033
708 MENTAL STATUS CHANGES 92 0.0033
709 NEOPLASM 38 0.0033
710 ABDOMINAL PAIN LOWER 83 0.0033
711 HYPERHIDROSIS 422 0.0033
712 CANDIDA INFECTION 55 0.0033
713 ANOSMIA 47 0.0032
714 ARTHRALGIA 1349 0.0032
715 LOWER RESPIRATORY TRACT INFECTION 147 0.0032
716 COLON CANCER 48 0.0032
717 PERIPHERAL SWELLING 496 0.0032
718 MYALGIA 546 0.0032
719 MENSTRUATION IRREGULAR 86 0.0032
720 GASTROINTESTINAL CARCINOMA 29 0.0032
721 TREATMENT FAILURE 263 0.0032
722 BLOOD SODIUM DECREASED 59 0.0031
723 DIARRHOEA 2000 0.0031
724 VOMITING 1456 0.0031
725 CELLULITIS 156 0.0031
726 AGEUSIA 77 0.0031
727 LIVER INJURY 75 0.0031
728 SKIN LACERATION 33 0.0030
729 WOUND 84 0.0030
730 ACNE 227 0.0030
731 HYPERBILIRUBINAEMIA 31 0.0030
732 FEEDING DISORDER 60 0.0030
733 BACTERIAL INFECTION 55 0.0029
734 THERAPEUTIC RESPONSE UNEXPECTED 132 0.0029
735 GINGIVAL BLEEDING 40 0.0029
736 LEUKOCYTOSIS 53 0.0029
737 TOOTH DISORDER 65 0.0029
738 BLISTER 164 0.0029
739 THROAT IRRITATION 131 0.0029
740 ISCHAEMIC STROKE 52 0.0029
741 PALLOR 79 0.0029
742 HYPOTENSION 581 0.0029
743 PRURITUS GENERALISED 62 0.0029
744 SKIN DISORDER 95 0.0028
745 EYELID OEDEMA 33 0.0028
746 HYPERTHYROIDISM 41 0.0028
747 HELICOBACTER INFECTION 29 0.0028
748 SWELLING 264 0.0028
749 METASTASES TO BONE 46 0.0028
750 HIP FRACTURE 90 0.0028
751 PERICARDITIS 47 0.0028
752 PHARYNGEAL OEDEMA 43 0.0028
753 DYSMENORRHOEA 37 0.0028
754 SKIN REACTION 39 0.0028
755 MENSTRUATION DELAYED 30 0.0028
756 HAEMOGLOBIN DECREASED 284 0.0028
757 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 496 0.0027
758 ADVERSE REACTION 36 0.0027
759 ILL-DEFINED DISORDER 164 0.0027
760 THROAT TIGHTNESS 73 0.0027
761 HEPATOTOXICITY 60 0.0027
762 GALLBLADDER DISORDER 48 0.0027
763 GASTRIC ULCER 51 0.0027
764 DRUG-INDUCED LIVER INJURY 84 0.0027
765 JAUNDICE 72 0.0027
766 STAPHYLOCOCCAL INFECTION 88 0.0027
767 ASPIRATION 29 0.0026
768 ACUTE MYOCARDIAL INFARCTION 78 0.0026
769 HEPATIC FUNCTION ABNORMAL 98 0.0026
770 VENTRICULAR TACHYCARDIA 43 0.0026
771 ECZEMA 136 0.0026
772 TENDON RUPTURE 32 0.0026
773 CONDITION AGGRAVATED 786 0.0026
774 DERMATITIS 54 0.0026
775 OCULAR HYPERAEMIA 122 0.0026
776 ABNORMAL BEHAVIOUR 101 0.0025
777 ILLNESS 262 0.0025
778 ABDOMINAL DISTENSION 265 0.0025
779 HERNIA 49 0.0025
780 METASTASES TO LUNG 29 0.0025
781 GASTROOESOPHAGEAL REFLUX DISEASE 202 0.0025
782 TRANSIENT ISCHAEMIC ATTACK 84 0.0025
783 CLOSTRIDIUM DIFFICILE INFECTION 54 0.0025
784 BLOOD CREATINE PHOSPHOKINASE INCREASED 71 0.0025
785 UNDERDOSE 180 0.0025
786 RASH 1070 0.0025
787 ERECTILE DYSFUNCTION 63 0.0025
788 ULCER 39 0.0024
789 METASTASES TO LIVER 43 0.0024
790 FLATULENCE 138 0.0024
791 CEREBROVASCULAR ACCIDENT 411 0.0024
792 DIVERTICULITIS 67 0.0024
793 SUICIDAL IDEATION 221 0.0024
794 DEHYDRATION 321 0.0024
795 ARTHRITIS 189 0.0024
796 ENCEPHALOPATHY 59 0.0024
797 DRUG INEFFECTIVE 3160 0.0024
798 DEMENTIA 67 0.0024
799 HAEMATOMA 62 0.0024
800 EJECTION FRACTION DECREASED 37 0.0024
801 FRACTURE 45 0.0024
802 OSTEOMYELITIS 43 0.0024
803 DIABETES MELLITUS 181 0.0024
804 MIDDLE INSOMNIA 44 0.0024
805 MYOCARDIAL INFARCTION 408 0.0023
806 BONE PAIN 137 0.0023
807 LABORATORY TEST ABNORMAL 69 0.0023
808 BLOOD LACTATE DEHYDROGENASE INCREASED 37 0.0023
809 CORONARY ARTERY OCCLUSION 32 0.0023
810 GASTRIC DISORDER 80 0.0023
811 NEUROPATHY PERIPHERAL 221 0.0023
812 RASH GENERALISED 60 0.0023
813 OSTEOARTHRITIS 98 0.0023
814 RENAL DISORDER 107 0.0023
815 LUNG NEOPLASM MALIGNANT 94 0.0023
816 RESPIRATORY TRACT CONGESTION 36 0.0023
817 MYDRIASIS 29 0.0023
818 ABSCESS 36 0.0023
819 EXPIRED PRODUCT ADMINISTERED 75 0.0023
820 METASTASES TO CENTRAL NERVOUS SYSTEM 29 0.0022
821 ORTHOSTATIC HYPOTENSION 39 0.0022
822 ATRIAL FIBRILLATION 218 0.0022
823 RASH MACULAR 78 0.0022
824 DISEASE PROGRESSION 263 0.0022
825 PLATELET COUNT DECREASED 236 0.0022
826 VAGINAL HAEMORRHAGE 96 0.0022
827 UNRESPONSIVE TO STIMULI 57 0.0022
828 COMA 105 0.0022
829 HAEMATURIA 75 0.0022
830 RESTLESSNESS 80 0.0022
831 PSYCHOTIC DISORDER 64 0.0022
832 HAEMORRHOIDS 42 0.0022
833 PNEUMONIA 697 0.0022
834 SPINAL FRACTURE 43 0.0021
835 NEUTROPENIA 291 0.0021
836 EPISTAXIS 160 0.0021
837 TYPE 2 DIABETES MELLITUS 72 0.0021
838 LUNG INFECTION 33 0.0021
839 ALTERED STATE OF CONSCIOUSNESS 46 0.0021
840 MENINGIOMA 33 0.0021
841 PSYCHOMOTOR HYPERACTIVITY 35 0.0021
842 RESPIRATORY DISORDER 63 0.0021
843 CYANOSIS 33 0.0021
844 ASTHMA 237 0.0021
845 PARANOIA 36 0.0021
846 EYE IRRITATION 120 0.0021
847 EYE PRURITUS 70 0.0021
848 PRURITUS 799 0.0021
849 DYSPNOEA EXERTIONAL 78 0.0021
850 JOINT SWELLING 249 0.0021
851 CIRCULATORY COLLAPSE 35 0.0021
852 FLUID RETENTION 104 0.0020
853 AGITATION 149 0.0020
854 SWELLING FACE 131 0.0020
855 LOCALISED INFECTION 48 0.0020
856 BLOOD POTASSIUM INCREASED 32 0.0020
857 URTICARIA 330 0.0020
858 FEMUR FRACTURE 61 0.0020
859 ANAEMIA 375 0.0020
860 CEREBRAL HAEMORRHAGE 70 0.0020
861 OEDEMA 106 0.0020
862 COLITIS 74 0.0020
863 RETCHING 41 0.0019
864 DEPRESSED LEVEL OF CONSCIOUSNESS 76 0.0019
865 CARDIOVASCULAR DISORDER 48 0.0019
866 NIGHTMARE 65 0.0019
867 SEPSIS 208 0.0019
868 WHEEZING 110 0.0019
869 RASH PRURITIC 100 0.0018
870 PAIN OF SKIN 49 0.0018
871 SUICIDE ATTEMPT 110 0.0018
872 ERYTHEMA 369 0.0018
873 ERUCTATION 34 0.0018
874 HYPOKALAEMIA 81 0.0018
875 BLOOD GLUCOSE INCREASED 324 0.0017
876 ANHEDONIA 45 0.0017
877 SWOLLEN TONGUE 53 0.0017
878 THERAPY NON-RESPONDER 76 0.0017
879 PERICARDIAL EFFUSION 39 0.0017
880 RASH ERYTHEMATOUS 79 0.0017
881 INJURY 116 0.0016
882 BREAST CANCER FEMALE 44 0.0016
883 PANCREATITIS 87 0.0016
884 DIABETES MELLITUS INADEQUATE CONTROL 29 0.0016
885 PRODUCT PHYSICAL ISSUE 33 0.0016
886 OSTEOPOROSIS 67 0.0016
887 CHOLESTASIS 31 0.0016
888 ACUTE RESPIRATORY FAILURE 31 0.0016
889 ARTHROPATHY 88 0.0016
890 TASTE DISORDER 32 0.0016
891 FAECES DISCOLOURED 34 0.0016
892 GLOSSODYNIA 35 0.0016
893 THROMBOSIS 125 0.0016
894 SKIN ULCER 40 0.0015
895 LUNG DISORDER 75 0.0015
896 FREQUENT BOWEL MOVEMENTS 41 0.0015
897 PRODUCT PRESCRIBING ERROR 36 0.0015
898 PULMONARY EMBOLISM 143 0.0015
899 BLOOD CREATININE INCREASED 97 0.0015
900 ABNORMAL DREAMS 41 0.0015
901 EXPOSURE DURING PREGNANCY 91 0.0015
902 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 70 0.0015
903 DRUG INTERACTION 230 0.0014
904 PROCEDURAL PAIN 40 0.0014
905 HAEMORRHAGE 150 0.0014
906 STOMATITIS 85 0.0014
907 PRODUCT USE IN UNAPPROVED INDICATION 345 0.0014
908 LIP SWELLING 46 0.0014
909 NO ADVERSE EVENT 250 0.0014
910 CORONARY ARTERY DISEASE 41 0.0014
911 ADVERSE DRUG REACTION 119 0.0013
912 AGGRESSION 66 0.0013
913 THROMBOCYTOPENIA 147 0.0013
914 HALLUCINATION 98 0.0013
915 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
916 CEREBRAL INFARCTION 31 0.0013
917 BLOOD GLUCOSE DECREASED 60 0.0012
918 DELIRIUM 43 0.0012
919 RESPIRATORY FAILURE 90 0.0012
920 RESPIRATORY DISTRESS 34 0.0012
921 PLEURAL EFFUSION 74 0.0012
922 RECTAL HAEMORRHAGE 52 0.0012
923 DRUG ADMINISTRATION ERROR 37 0.0012
924 DRUG DOSE OMISSION 194 0.0012
925 WITHDRAWAL SYNDROME 49 0.0012
926 SYSTEMIC LUPUS ERYTHEMATOSUS 41 0.0012
927 HYPOPHAGIA 29 0.0011
928 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 59 0.0011
929 PANCYTOPENIA 63 0.0011
930 DEEP VEIN THROMBOSIS 73 0.0011
931 ASCITES 33 0.0011
932 DRY SKIN 149 0.0011
933 PANCREATIC CARCINOMA 32 0.0011
934 CARDIAC ARREST 91 0.0011
935 HYPERGLYCAEMIA 40 0.0011
936 PSORIASIS 143 0.0011
937 HEPATIC FAILURE 33 0.0011
938 HYPOXIA 38 0.0011
939 SKIN BURNING SENSATION 76 0.0011
940 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
941 SKIN EXFOLIATION 89 0.0011
942 OXYGEN SATURATION DECREASED 58 0.0010
943 INTENTIONAL OVERDOSE 66 0.0010
944 PULMONARY OEDEMA 46 0.0010
945 HAEMATOCHEZIA 56 0.0010
946 RENAL IMPAIRMENT 84 0.0010
947 THERAPEUTIC RESPONSE DECREASED 58 0.0010
948 PRODUCT SUBSTITUTION ISSUE 55 0.0010
949 INJECTION SITE REACTION 65 0.0009
950 OSTEONECROSIS 31 0.0009
951 INTESTINAL OBSTRUCTION 35 0.0009
952 CARDIAC FAILURE 71 0.0009
953 SEPTIC SHOCK 38 0.0009
954 COLITIS ULCERATIVE 38 0.0008
955 HYPERKALAEMIA 29 0.0008
956 MEDICATION ERROR 45 0.0008
957 HYPONATRAEMIA 45 0.0008
958 THERAPY INTERRUPTED 57 0.0008
959 OVERDOSE 170 0.0008
960 PRODUCT USE ISSUE 148 0.0008
961 RENAL CANCER 37 0.0008
962 ANAPHYLACTIC REACTION 42 0.0008
963 ADVERSE EVENT 66 0.0007
964 OFF LABEL USE 619 0.0007
965 ANGIOEDEMA 31 0.0007
966 HYPOGLYCAEMIA 33 0.0007
967 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 48 0.0007
968 RENAL FAILURE 89 0.0007
969 BLADDER CANCER 38 0.0006
970 DEATH 550 0.0006
971 EMOTIONAL DISTRESS 76 0.0006
972 COMPLETED SUICIDE 52 0.0006
973 DRUG EFFECT DECREASED 33 0.0006
974 INTENTIONAL PRODUCT USE ISSUE 50 0.0006
975 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
976 DRUG WITHDRAWAL SYNDROME 49 0.0006
977 UNEVALUABLE EVENT 41 0.0005
978 INTENTIONAL PRODUCT MISUSE 47 0.0005
979 INCORRECT DOSE ADMINISTERED 114 0.0005
980 INFUSION RELATED REACTION 31 0.0005
981 CARDIAC FAILURE CONGESTIVE 37 0.0005
982 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
983 RHEUMATOID ARTHRITIS 46 0.0004
984 PROSTATE CANCER 30 0.0004
985 PRODUCT STORAGE ERROR 31 0.0004
986 ACUTE KIDNEY INJURY 53 0.0003
987 HOSPITALISATION 42 0.0003
988 TOXICITY TO VARIOUS AGENTS 46 0.0003
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 42 0.0002
990 DRUG DEPENDENCE 31 0.0002
991 INJECTION SITE PAIN 55 0.0002